International news in seven languages
Topic
A growing Bundibugyo virus outbreak is showing how a little-known relative of Ebola can become a major threat when diagnosis and treatment options are limited. Experts warn that preparing only for familiar pathogens could leave the world vulnerable when rare but deadly viruses suddenly reemerge.
DR Congo is rolling out vaccine trials for health workers at the centre of the country’s Ebola crisis.
50,000 frontline staff to receive a jab for a different Ebola strain, with 20,000 enrolled in a one-year clinical trial.
In the Democratic Republic of Congo, the government claims that the Ebola outbreak has changed course, with cases trending downwards in hotspots. But that interpretation is being met with pushback from experts and health responders, who say the outbreak remains as bad as ever. Details by FRANCE 24 correspondent Emmet Livingstone.
Doctors Without Borders has warned against premature optimism amid the DRC's largest-ever Ebola outbreak. "The outbreak is not shrinking, it is moving," an MSF official said, entering new and more underprepared regions.
The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.
